Novartis financial results Q2 2024

Novartis Financial Results – Q2 2024

Novartis announced the company’s financial results for the second quarter and first half of 2024.

A highly trained Novartis specialist dresses in full personal protective equipment to work on the radioligand therapy production line

Drug delivery, service delivery, and the future of cancer care

State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.

Scientist in lab

Beacon of Hope

Novartis is expanding the Beacon of Hope program through new collaborations to address systemic health disparities.